Webinar

Lunaphore Spatial Biology Week 2021

Watch Now On-Demand

December 6-11 2021

On demand

Online

Spatial Biology Week 2021

Lunaphore is pleased to invite you to the Lunaphore Spatial Biology Week.

This 5-day online meeting brings scientific experts from the industry and academic research institutions. Covering research topics from immuno-oncology, pathology, immunology, and infectious diseases, this event will feature talks on cutting-edge research in spatial biology.

Spatial biology is the new frontier in life sciences. However, high complexity and technical barriers still prevent its wide adoption in translational research. This conference aims to highlight how new technology solutions are lowering these barriers for adoption in a wide range of research laboratories in hospitals, academia, core facilities, and biopharma.

Gain comprehensive insights into spatial biology research applications through interactive sessions and engaging presentations. The event agenda will feature talks, workshops, and roundtable discussions. Registration is free and open to researchers from Europe and North America.

Can anyone register? How much is the registration?

The registration is free and open to everyone.

Where does the event take place?

Lunaphore’s Spatial Biology Week will be online.

How can I connect?

You will receive a confirmation email upon registration with a link that will give you access to all presentations.

Do I have to connect to each presentations individually?

No, you only need to register once. The link in your confirmation email will then give you access to all presentations.

Can I watch a presentation on-demand?

Yes, all presentations will be available on-demand.

Monday, 6 December, 2021

From protein to RNA study: educational series on spatial biology

4:00 PM CET | 10:00 AM EST

Speaker

Alexandre Kehren

Alexandre Kehren

Application Development Team Leader

Lunaphore

4:30 PM CET | 10:30 AM EST

Speaker

Deniz Eroglu

Deniz Eroglu

Project Manager Scientific Affairs

Lunaphore

Deniz received his bachelor’s degree in Electrical & Electronics Engineering in 2009 and his master’s degree in Microsystems in 2012 from METU, Ankara, Turkey, where he worked on developing novel microresonant mass sensors for cell detection applications.

After spending two years as a research assistant at EPFL, he started working at Lunaphore on a short-term Intellectual Property (IP) project. He then joined the company full-time in October 2015 as Intellectual Property Manager. He is responsible for managing the IP portfolio, advising the management on IP strategy, and gathering and structuring information on critical topics relevant to strategic decision-making.

Tuesday, 7 December, 2021

From fundamental to translational research: spatial biology for all laboratories

4:00 PM CET | 10:00 AM EST

Speaker

Dr. Charlotte Stadler

Dr. Charlotte Stadler

Head of the National Spatial Proteomics Facility

SciLifeLab, Sweden

Charlotte started her research as a Ph.D. student within the Human Protein Atlas program in 2008, focusing on developing protocols and validation methods for subcellular mapping of the human proteome using imaging. She is now Head of the National Spatial Proteomics Facility located at Science for Life Laboratories, where their focus lies in multiplexed immunofluorescence imaging. Their close link to the Human Protein Atlas puts them in a unique position as they have access to a proteome-wide antibody library that allows for the detection of most human protein targets in many applications.

4:30 PM CET | 10:30 AM EST

Speaker

Dr. Alexander Klimowicz

Dr. Alexander Klimowicz

Senior Principal Scientist

Boehringer Ingelheim Pharmaceuticals, USA

Alex Klimowicz is a Senior Principal Scientist in the Department of Immunology and Respiratory Discovery Research at Boehringer Ingelheim Pharmaceuticals, Inc. In this capacity he leads the Molecular Histopathology Group, implementing and applying cutting edge in situ techniques, whole slide imaging, and digital image analysis to deliver translational human disease data to support drug programs and define human patient segments to enable precision medicine. Alex holds a Ph.D. in Molecular Biology and has over ten years of experience in digital pathology and quantitative immunohistochemistry. Before moving to Boehringer Ingelheim, Alex was an Adjunct Research Assistant Professor in the Department of Oncology at the University of Calgary. He led a core quantitative immunohistochemistry lab focused on cancer biomarker research.

5:00 PM CET | 11:00 AM EST

Speakers

Dr. Ece Kadioglu

Dr. Ece Kadioglu

Field Application Specialist

Lunaphore

Emilie Peres

Emilie Peres

Application Development Engineer

Lunaphore

Wednesday, 8 December, 2021

Spatial profiling: a tool with multiple uses

4:00 PM CET | 10:00 AM EST

Speaker

Dr. Matthew Pugh

Dr. Matthew Pugh

MRC Clinical Research Training Fellow

University of Birmingham, UK

Dr. Matthew Pugh is a pathologist specializing in diagnostic haematopathology and an MRC clinical research fellow at the University of Birmingham. His research interests include the immune control of viruses, including Epstein Barr virus and SARS-CoV-2.

4:30 PM CET | 10:30 AM EST

Speaker

Jonathan Mignot

Jonathan Mignot

Application Development Scientist

Lunaphore

Thursday, 9 December, 2021

The future of spatial biology: technological advances and immunotherapy

4:00 PM CET | 10:00 AM EST

Speakers

Dr. Inti Zlobec

Dr. Inti Zlobec

Head of the Translational Research Unit (TRU)

University of Bern, Switzerland

Inti Zlobec received her Ph.D. in Experimental Medicine (Pathology) from McGill University in Montreal. By combining her interests in pathology and biostatistics, she has developed biostatistical models for predicting response to preoperative radiotherapy in patients with rectal cancer and optimized workflows for biomarker analysis. In 2011, she received the title of ‘Privatdozentin’ from the University of Basel. Today, Inti Zlobec works as Associate Professor at the University of Bern, where she leads the Translational Research Unit and Tissue Bank Bern. She is Chair of the Working Group IT for the European Society of Pathology and President of the Swiss Consortium for Digital Pathology (SDiPath). Her research group includes a multi-disciplinary team using experimental methods and digital pathology to gain insights into the biology of colorectal cancers, their molecular subtypes, prognoses, and therapy responsiveness to improve patient management.

Dr. Andrew Janowczyk

Dr. Andrew Janowczyk

Assistant Research Professor

Department of Biomedical, Engineering, Case School of Engineering, United States

Dr. Andrew Janowczyk is an Assistant Research Professor at The Center of Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University and a Senior Research Scientist in the Precision Oncology Center at the Lausanne University Hospital (CHUV), Switzerland. He has applied computer vision algorithms to digital pathology images for over ten years. One of his areas of expertise is leveraging deep learning to build computational models to aid pathologists in many everyday tasks, such as disease detection and grading. Dr. Janowczyk’s 2016 Journal of Pathology Informatics Paper entitled “Deep learning for digital pathology image analysis: A comprehensive tutorial with selected use cases” (over 30k views) laid out a generalized approach via open-sourced code and datasets to facilitate the development of the next generation of data scientists. In 2018, his tool “HistoQC: A quality control pipeline for digital pathology slides” received the Innovation Award at the European Congress of Digital Pathology (ECDP). He helped co-found and was elected secretary of the Swiss Digital Pathology Consortium (SDiPath). His newer research focuses on the tasks of predicting prognosis and therapy response. He maintains a research-oriented blog, andrewjanowczyk.com, which aims to provide the research community with digital pathology-related insights, code, and datasets.

5:00 PM CET | 11:00 AM EST

Speaker

Dr. Taha Merghoub

Dr. Taha Merghoub

Attending Biologist, Human Oncology & Pathogenesis Program Co-director, Ludwig Collaborative & Swim Across America Laboratory, Memorial Sloan Kettering Professor of Immunology Research in Medicine, Weill Cornell Medical College Member Researcher

Parker Institute for Cancer Immunotherapy

Dr. Merghoub directs the Ludwig Collaborative Laboratory and the Swim Across America Laboratory at Memorial Sloan Kettering (MSK). I am a member researcher of the Parker Institute for Cancer Immunotherapy at MSK. I also lead the biorepository for the Melanoma Service at MSK. My research project investigates the means for developing immune-based therapies to treat cancer. In addition, some of my work aims to study the pathogenesis and treatment of melanoma as a model system and is directed in part at developing tools to study melanoma, lung cancer, and immune responses in multiple cancers. My projects are heavily collaborative across different disciplines at MSK.

Friday, 10 December, 2021

Spatial biology: workshops and satellite session

4:00 PM CET | 10:00 AM EST

Speaker

Dr. Michael Surace

Dr. Michael Surace

Associate Director

AstraZeneca, USA

Michael Surace received a BS in Biology from James Madison University in 2004 before joining the Medical Automation Research Center in the Department of Pathology at the University of Virginia. In 2006 he began graduate studies in the laboratory of Dr. Liwu Li, working on nuclear receptor and TLR signaling network crosstalk and its role in the polarization of macrophage activation phenotypes (M1/M2). He received his Ph.D. from Virginia Tech in 2010. Postdocs were at the Medical College of Virginia at Virginia Commonwealth University in Richmond, Virginia, in the departments of Anatomy and Neurobiology, investigating the cellular mechanisms of microglial activation in response to toxic insult in Parkinson’s Disease and Molecular Biology and Biochemistry, working on astrocytes as inflammatory immune cells in multiple sclerosis. In 2015 he joined STCube Pharmaceuticals as a research scientist characterizing novel immune checkpoint inhibitor antibodies with multiplex immunofluorescence and digital pathology image analysis to support mechanistic action research. In 2017 he joined Medimmune/ AstraZeneca as a scientist developing and validating Multiplex IF panels. Since then, he has continued developing the mIF platform inside Translational Medicine Oncology, focusing on validation of panels, reproducibility across sites, and improving the image and data analysis pipelines for research and clinical trials to support the development of predictive and prognostic models incorporating multiple markers and spatial information.

4:30 PM CET | 10:30 AM EST

Speaker

Dr. Sara Milosevic

Dr. Sara Milosevic

Sales Specialist

Lunaphore

5:00 PM CET | 11:00 AM EST

Speaker

Everton Robinson

Everton Robinson

VP Sales and Customer Support

Lunaphore

Related Events